Tang C - Search Results

1

Bone marrow-derived cells contribute to NDEA-induced lung squamous cell carcinoma.

Luo D, Liu D, Zhou X, Yang S, Tang C, Liu G. Luo D, et al. Among authors: tang c. Tumour Biol. 2013 Feb;34(1):145-54. doi: 10.1007/s13277-012-0522-0. Epub 2012 Oct 2. Tumour Biol. 2013. PMID: 23055190

2

[Expression and its clinical significance of SHP2 in non-small cell lung cancer].

Tang C, Zhou X, Yang H, Wang Q, Zhang R. Tang C, et al. Zhongguo Fei Ai Za Zhi. 2010 Feb;13(2):98-101. doi: 10.3779/j.issn.1009-3419.2010.02.03. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20673499 Free PMC article. Chinese.

3

[Advances of DNA damage repair and Cisplatin resistance mechanisms in lung cancer].

Tang C, Yang H, Zhou X. Tang C, et al. Zhongguo Fei Ai Za Zhi. 2011 Dec;14(12):960-4. doi: 10.3779/j.issn.1009-3419.2011.12.11. Zhongguo Fei Ai Za Zhi. 2011. PMID: 22152698 Free PMC article. Review. Chinese.

4

Expression of SHP2 and related markers in non-small cell lung cancer: a tissue microarray study of 80 cases.

Tang C, Luo D, Yang H, Wang Q, Zhang R, Liu G, Zhou X. Tang C, et al. Appl Immunohistochem Mol Morphol. 2013 Oct;21(5):386-94. doi: 10.1097/PAI.0b013e31827da3f9. Appl Immunohistochem Mol Morphol. 2013. PMID: 23343958

5

Role of Wnt Inhibitory Factor-1 in Inhibition of Bisdemethoxycurcumin Mediated Epithelial-to-Mesenchymal Transition in Highly Metastatic Lung Cancer 95D Cells.

Xu JH, Yang HP, Zhou XD, Wang HJ, Gong L, Tang CL. Xu JH, et al. Chin Med J (Engl). 2015 May 20;128(10):1376-83. doi: 10.4103/0366-6999.156795. Chin Med J (Engl). 2015. PMID: 25963361 Free PMC article.

6

Bisdemethoxycurcumin suppresses migration and invasion of highly metastatic 95D lung cancer cells by regulating E-cadherin and vimentin expression, and inducing autophagy.

Xu J, Yang H, Zhou X, Wang H, Gong L, Tang C. Xu J, et al. Among authors: tang c. Mol Med Rep. 2015 Nov;12(5):7603-8. doi: 10.3892/mmr.2015.4356. Epub 2015 Sep 24. Mol Med Rep. 2015. PMID: 26459909

7

Therapeutic outcomes of autologous CIK cells as a maintenance therapy in the treatment of lung cancer patients: A retrospective study.

Luo H, Gong L, Zhu B, Huang Y, Tang C, Yu S, Yang Z, Zhou X. Luo H, et al. Among authors: tang c. Biomed Pharmacother. 2016 Dec;84:987-993. doi: 10.1016/j.biopha.2016.10.022. Epub 2016 Oct 18. Biomed Pharmacother. 2016. PMID: 27764762

8

Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798.

Yang X, Tang C, Luo H, Wang H, Zhou X. Yang X, et al. Among authors: tang c. Oncotarget. 2017 Apr 4;8(14):23664-23674. doi: 10.18632/oncotarget.15641. Oncotarget. 2017. PMID: 28423588 Free PMC article.

9

Src homology phosphotyrosyl phosphatase 2 mediates cisplatin-related drug resistance by inhibiting apoptosis and activating the Ras/PI3K/Akt1/survivin pathway in lung cancer cells.

Tang C, Luo H, Luo D, Yang H, Zhou X. Tang C, et al. Oncol Rep. 2018 Feb;39(2):611-618. doi: 10.3892/or.2017.6109. Epub 2017 Nov 24. Oncol Rep. 2018. PMID: 29207183

10

Mesenchymal stem cells promote cell invasion and migration and autophagy-induced epithelial-mesenchymal transition in A549 lung adenocarcinoma cells.

Luo D, Hu S, Tang C, Liu G. Luo D, et al. Among authors: tang c. Cell Biochem Funct. 2018 Mar;36(2):88-94. doi: 10.1002/cbf.3320. Epub 2018 Jan 25. Cell Biochem Funct. 2018. PMID: 29372557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,590 results

Search Page

Filters